Skip to main navigation

Skip to Content

Live - Investor Relations & Corporate Menu

Science
News
About
Investors
- Company Presentations
- Financial Information
  - SEC Filings
  - Annual Reports
Clinical Trials
We're Hiring
Resources

Sign Up for Alerts

Company Presentations

Company Presentations

Presentations

Cassava Corporate Presentation – November 2023 3.3 MB

CTAD 2023 “Results of a Phase 2 Randomized Withdrawal Study of Simufilam in Mild-to-moderate Alzheimer’s Disease” 3.3 MB

CTAD 2023 Poster Presentation “Simufilam’s Primary Mechanism of Action Confirmed by Time-resolved FRET” 518.6 KB

CTAD 2023 Poster Publication “Interim MRI Safety Analysis From a 76-week Phase 3 Clinical Trial of Simufilam in Alzheimer’s Disease” 592.4 KB

CTAD 2022 Poster – A. Mammel, Neurocode 1.2 MB

CTAD 2021 Poster 340.6 KB

Past Events

Jefferies - Inaugural Biotech CNS/Neuro Summit

Oct 11, 2023
10:30 AM EDT

Corporate presentation by Remi Barbier, President & CEO

Click here for webcast

Location

New York City

JonesTrading - 2023 Healthcare Summit

Oct 10, 2023

Investor meetings with management

Location

Miami

H.C. Wainwright - 25th Annual Global Investment Conference

Sep 11, 2023

Corporate presentation by Eric Schoen, Chief Financial Officer

Location

New York City

Morgan Stanley - 21st Annual Global Healthcare Conference

Sep 11, 2023

Fireside chat with Remi Barbier, President & CEO

Location

New York City

Shareholder Tools - ACTIVE

Print Page

Sign Up for Alerts

RSS News Feeds

Contact Us

© 2023 Cassava Sciences, Inc.

Live - Investor Relations & Corporate Menu

Science
News
About
Investors
Clinical Trials
We're Hiring
Resources